FUJIFILM Diosynth Biotechnologies (Fujifilm), a CDMO with experience in the development and manufacture of recombinant biopharmaceuticals and gene therapies, has introduced its next generation Apollo mammalian expression system, Apollo X. The Apollo X advanced mammalian expression system is capable of delivering industry leading titres in excess of 10 g/L and is designed to be a ‘manufacturing-ready’ cell line with a robust support package to aid IND filing.   “We have focus...